Neuberger Berman Group’s NeoGenomics NEO Stock Holding History

Neuberger Berman Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$169K	Buy	+11,615	New	+$112K	﹤0.01%	2200
2022 Q1	–	Sell	-126,479	Closed	-$4.25M	–	1958
2021 Q4	$4.25M	Sell	126,479 -838	-0.7%	-$32.8K	﹤0.01%	1017
2021 Q3	$6.01M	Buy	127,317 +3,151	+3%	+$146K	0.01%	914
2021 Q2	$5.59M	Sell	124,166 -16,698	-12%	-$740K	﹤0.01%	931
2021 Q1	$6.78M	Buy	140,864 +25,114	+22%	+$1.31M	0.01%	894
2020 Q4	$6.22M	Buy	115,750 +23,100	+25%	+$1.04M	0.01%	866
2020 Q3	$3.41M	Buy	92,650 +350	+0.4%	+$13K	﹤0.01%	946
2020 Q2	$2.85M	Buy	92,300 +50,300	+120%	+$1.39M	﹤0.01%	942
2020 Q1	$1.16M	Hold	42,000	–	–	﹤0.01%	1069
2019 Q4	$1.23M	Hold	42,000	–	–	﹤0.01%	1122
2019 Q3	$803K	Buy	+42,000	New	+$985K	﹤0.01%	1189

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Neuberger Berman Group's NEO Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in NeoGenomics (NEO) in Q2 2026: 11,615 shares worth $169K. The stake represents ﹤0.01% of the portfolio and ranks #2200 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in NEO as recently as Q4 2021.

Neuberger Berman Group first reported a position in NEO in Q3 2019 and has held it in 11 quarters since. The position peaked at $6.78M in Q1 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Neuberger Berman Group held 11,615 shares of NeoGenomics worth $169K as of Q2 2026.
NeoGenomics was a new Neuberger Berman Group position in Q2 2026.
NeoGenomics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2200 holding.
Neuberger Berman Group first reported a position in NeoGenomics in Q3 2019 and has held it in 11 quarters since.
Neuberger Berman Group's NeoGenomics position peaked at $6.78M in Q1 2021.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.